APA (7th ed.) Citation

F, C., C, B., MT, S., A, B., C, T., M, S., . . . K, F. (2009). Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): A non-randomised phase I-II study. Lancet Oncology, 10(5), 489. https://doi.org/10.1016/s1470-2045(09)70074-9

Chicago Style (17th ed.) Citation

F, Ciceri, et al. "Infusion of Suicide-gene-engineered Donor Lymphocytes After Family Haploidentical Haemopoietic Stem-cell Transplantation for Leukaemia (the TK007 Trial): A Non-randomised Phase I-II Study." Lancet Oncology 10, no. 5 (2009): 489. https://doi.org/10.1016/s1470-2045(09)70074-9.

MLA (9th ed.) Citation

F, Ciceri, et al. "Infusion of Suicide-gene-engineered Donor Lymphocytes After Family Haploidentical Haemopoietic Stem-cell Transplantation for Leukaemia (the TK007 Trial): A Non-randomised Phase I-II Study." Lancet Oncology, vol. 10, no. 5, 2009, p. 489, https://doi.org/10.1016/s1470-2045(09)70074-9.